Showing results (431-440 of 558) with videos related to

Sort By:
Pageof 56
British Journal of Pharmacology|December 6, 2002
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2Nicole Sawyer, Elizabeth Cauchon, Anne Chateauneuf, et al.
British Journal of Clinical Pharmacology|April 1, 1987
A quinine a day keeps the leg cramps away?A Warburton, J P Royston, C J O'Neill, et al.
Blood|March 1, 1981
The reversible binding of vinblastine to platelets: implications for therapyJ G Kelton, J W McDonald, R M Barr, et al.
Optics Express|October 6, 2012
Measuring higher-order modes in a low-loss, hollow-core, photonic-bandgap fiberJ W Nicholson, L Meng, J M Fini, et al.
Oncogene|February 1, 1996
Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymeraseC A Boulakia, G Chen, F W Ng, et al.
Nature Communications|October 29, 2014
Polarization maintaining single-mode low-loss hollow-core fibresJohn M Fini, Jeffrey W Nicholson, Brian Mangan, et al.
Optics Express|August 20, 2010
A higher-order-mode erbium-doped-fiber amplifierJ W Nicholson, J M Fini, A M DeSantolo, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopaA L Leeman, C J O'Neill, P W Nicholson, et al.
Age and Ageing|March 1, 1988
Pressure sores: effect of Parkinson's disease and cognitive function on spontaneous movement in bedP W Nicholson, A L Leeman, C J O'Neill, et al.
British Journal of Clinical Pharmacology|February 1, 1990
Parkinsonian abnormality of foot strike: a phenomenon of ageing and/or one responsive to levodopa therapy?J R Hughes, S G Bowes, A L Leeman, et al.
Pageof 56